• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.

作者信息

Althausen A F, Prout G R, Daly J J

出版信息

J Urol. 1976 Nov;116(5):575-80. doi: 10.1016/s0022-5347(17)58916-8.

DOI:10.1016/s0022-5347(17)58916-8
PMID:978809
Abstract

We evaluated 129 patients with low grade, low stage transitional cell carcinoma of the bladder with a minimum followup of 5 years. In addition to the phenomena recognized as indicators of a serious clinical problem (grade greater than I, rapid recurrence, multiple tumors and lamina propria invasion) the identification of carcinoma in situ and/or atypia in normal, incidentally resected mucosa adjacent to the tumor was found to be a positive predictor for subsequent muscle invasion. Ten of 12 patients with carcinoma in situ and 9 of 25 patients with atypia were among 39 who experienced invasion.

摘要

相似文献

1
Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.
J Urol. 1976 Nov;116(5):575-80. doi: 10.1016/s0022-5347(17)58916-8.
2
Papillary adenocarcinoma in situ of bladder.膀胱原位乳头状腺癌
J Urol. 1985 Sep;134(3):544-6. doi: 10.1016/s0022-5347(17)47286-7.
3
Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.P53核积聚及组织病理学特征在膀胱T1期移行细胞癌中的预后价值
Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1.
4
Coexistence of papillary and nodular carcinomas in the urinary bladder.膀胱中乳头状癌与结节状癌并存。
Jpn J Clin Oncol. 1987 Jun;17(2):179-86.
5
Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.浅表性膀胱肿瘤患者的临床全尿路上皮疾病:治疗意义。
J Urol. 2002 May;167(5):2007-11.
6
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.高级别 T1 期与肌层浸润性膀胱癌中 PD-L1 的差异表达及其预后意义。
J Urol. 2017 Oct;198(4):817-823. doi: 10.1016/j.juro.2017.04.102. Epub 2017 May 6.
7
Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma.膀胱癌的预后。I. 浅表性移行细胞癌的危险因素。
Eur Urol. 1987;13(3):145-9.
8
Histological analysis of high-grade superficial bladder tumour.
Int Urol Nephrol. 1991;23(3):237-43. doi: 10.1007/BF02550418.
9
[Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].[膀胱前列腺切除标本中的前列腺移行细胞癌]
Aktuelle Urol. 2003 Sep;34(5):333-6. doi: 10.1055/s-2003-42002.
10
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.卡介苗维持免疫疗法用于复发性TA、T1期及原位膀胱移行细胞癌:西南肿瘤协作组的一项随机研究
J Urol. 2000 Apr;163(4):1124-9.

引用本文的文献

1
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ.不同阶段尿路上皮膀胱癌的蛋白质基因组学研究揭示了乳头状癌和原位癌的不同分子特征。
Nat Commun. 2023 Sep 13;14(1):5670. doi: 10.1038/s41467-023-41139-3.
2
URINE CYTOLOGY AND AXILLARY TESTING FOR INTERPRETATION AND FOLLOW-UP OF URINARY TUMORS.尿液细胞学检查和腋窝检测用于解读和随访泌尿系统肿瘤。
Acta Clin Croat. 2022 Nov;61(3):505-510. doi: 10.20471/acc.2022.61.03.16.
3
Low-Grade, Multiple, Ta Non-muscle-Invasive Bladder Tumors: Tumor Recurrence and Worsening Progression.
低级别、多发性、Ta期非肌层浸润性膀胱肿瘤:肿瘤复发与疾病进展恶化
Indian J Surg Oncol. 2018 Jun;9(2):157-161. doi: 10.1007/s13193-018-0728-8. Epub 2018 Jan 29.
4
Urethral carcinoma in situ: recognition and management.原位尿道癌:识别与管理
Int Urol Nephrol. 2017 Apr;49(4):637-641. doi: 10.1007/s11255-017-1512-3. Epub 2017 Jan 18.
5
Carbonic anhydrase 2 is a novel invasion-associated factor in urinary bladder cancers.碳酸酐酶2是膀胱癌中一种新的侵袭相关因子。
Cancer Sci. 2017 Mar;108(3):331-337. doi: 10.1111/cas.13143.
6
Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.1981 - 2014年挪威膀胱尿路上皮癌的发病率与生存率
BMC Cancer. 2016 Oct 13;16(1):799. doi: 10.1186/s12885-016-2832-x.
7
Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo.通过ICG pHLIP肽在体外对人膀胱尿路上皮癌进行靶向成像。
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11829-11834. doi: 10.1073/pnas.1610472113. Epub 2016 Sep 29.
8
Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma.在膀胱癌患者外观良性的膀胱组织中,干细胞标志物阳性的星状细胞和肥大细胞减少。
Virchows Arch. 2014 Apr;464(4):473-88. doi: 10.1007/s00428-014-1561-2. Epub 2014 Feb 26.
9
Prognostic value of cell-cycle regulation biomarkers in bladder cancer.细胞周期调控生物标志物在膀胱癌中的预后价值。
Semin Oncol. 2012 Oct;39(5):524-33. doi: 10.1053/j.seminoncol.2012.08.008.
10
Oncolytic viruses in the treatment of bladder cancer.溶瘤病毒在膀胱癌治疗中的应用
Adv Urol. 2012;2012:404581. doi: 10.1155/2012/404581. Epub 2012 Jul 29.